All the News in one place from Singapore
More than 50 news sites, more than 1000 pieces of news daily
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
(May 04 00:39) Businessinsider.sg
The nonprofit group often finds drugs to be overpriced. For the first potential COVID-19 drug, it says a price of up to $4,500 could be justified.
Share Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient on your favourite social media